Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: An active and low toxicity regimen

European Journal of Cancer

Volumn 38, Issue 9, 2002, Pages 1204-1211

  Feliu, J ^a   Mel, J R ^b   Camps, C ^c   Escudero, P ^c   Aparicio, J ^c   Menendez D ^d   Garcia Giron C ^c   Rodriguez, M R ^c   Sanchez J J ^e   Gonzalez Baron M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c Medical Oncology Service   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Chemotherapy; Colorectal cancer; Elderly; Raltitrexed; Toxicity

Indexed keywords

RALTITREXED;

ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; COLORECTAL CANCER; CONTROLLED STUDY; DEATH; DIARRHEA; DOSE RESPONSE; DRUG CYTOTOXICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; QUINAZOLINES; SEX FACTORS; SURVIVAL ANALYSIS; THIOPHENES; TREATMENT OUTCOME;

EID: 0036270715     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00005-9     Document Type: Article

References (28)

1. Cancer statistics
2. Colorectal cancer detection, treatment and rehabilitation
3. Survival of colorectal cancer patients in Europe during period 1978-1989
4. Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987
5. Should chemotherapy be used as a treatment of advnced colorectal carcinoma (ACC) in patients over 70 years age?: Contra
6. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial
7. Toxicities of fluorourcil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors
8. Comorbidity and colorectal cancer according to subsite stage: A population-based study
9. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
10. Expectancy of primary chemotherapy in patients with advanced asymtomatic colorectal cancer: A randomized trial
11. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patints with metastatic colorectal cancer
12. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
13. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
14. Adjuvant or palliative chemotherapy for colorrectal cancer in patients 70 years or older
15. Haematological and non-heamatological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number
16. 'Tomudex': A novel thymidilate synthase (TS) inhibitor with clinical antitumour activity in a range of solid tumours
17. 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia
18. Open, randomized multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer
19. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender,increasing age and cycle number
20. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and thethylene thiophosphoramine
21. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
22. Prediction of creatinine clearance from serum creatinine
23. Management of cancer in the older person: A practical approach
24. Advanced colorectal cancer in the elderly; Results of consecutive trials with 5-fluorouracil-based chemotherapy
25. A controlled study of supportive care (SC) versus SC plus 5-fluorouracil/folinic acid (Ff) for advanced metastatic gastrointestinal carcinomas (AMGG) in the elderly paients (pt)
26. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU+LV) in patients with advanced colorectal cancer (ACC): Results of a randomized, multicenter, North American trial
27. A survey of patients' perceptions of the convenience of different chemotherapy regimens for advanced colorectal cancer